Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Other Operating Expenses (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Other Operating Expenses for 16 consecutive years, with $13.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 6.4% to $13.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.5 million, a 16.53% increase, with the full-year FY2025 number at $54.5 million, up 16.53% from a year prior.
  • Other Operating Expenses was $13.4 million for Q4 2025 at Lemaitre Vascular, up from $11.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $14.9 million in Q2 2025 to a low of $2.6 million in Q1 2021.
  • A 5-year average of $10.3 million and a median of $11.0 million in 2024 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: crashed 66.96% in 2021, then skyrocketed 199.05% in 2022.
  • Lemaitre Vascular's Other Operating Expenses stood at $7.4 million in 2021, then grew by 15.51% to $8.6 million in 2022, then rose by 19.4% to $10.3 million in 2023, then rose by 22.96% to $12.6 million in 2024, then grew by 6.4% to $13.4 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Other Operating Expenses are $13.4 million (Q4 2025), $11.9 million (Q3 2025), and $14.9 million (Q2 2025).